Here's a look at some of the top legal news stories for medical device companies this week: Guidant can't slip breach-of-contract charges in Johnson & Johnson suit; Biomet reveals SEC subpoena over alleged 'improprieties' in Brazil, Mexico; Appeals court upholds Retractable Technologies win over Becton Dickinson; Board suspends ex-PricewaterhouseCoopers accountant over ArthroCare scandal; Covidien's Nellcor and CAS Medical settle dispute for $275k
, Becton Dickinson & Co.
, Boston Scientific
, CAS Medical Systems Inc.
, Dept. of Justice (DOJ)
, Guidant Corp.
, Johnson & Johnson
, Public Company Accounting Oversight Board
, Retractable Technologies Inc.
, Securities & Exchange Commission (SEC)
, Abbott Laboratories
Researchers use Intuitive Surgical's da Vinci robotic surgery system as a cautionary tale about the rapid adoption of new technologies that require physician training.
Covidien says its exposure to a raft of product liability lawsuits filed over pelvic mesh products increased by some $131 million during its fiscal 3rd quarter.
A Covidien shareholder files a purported class action lawsuit seeking to block the proposed, $43 billion merger of Medtronic and Covidien.
Here's a look at some of the top regulatory stories for medical device companies this week: Covidien taps integration chief to navigate Medtronic merger; Zimmer, Biomet appoint integration team; Thoratec inks $75M deal for Apica Cardiovascular; FTC wants more from Zimmer, Biomet on merger; Johnson & Johnson closes Ortho-Clinical Diagnostics sale
Covidien says its launched the latest version of the Trellis peripheral infusion system designed to dissolve blood clots above the knee.
Covidien (NYSE:COV) said today it's launched the Trellis clot-busting platform in the U.S., Europe and Canada.
Nellcor agrees to drop its litigation in return for a $275,000 payment and a promise from Nellcor to drop its claims for legal fees.